v3.26.1
CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Statement of Comprehensive Income [Abstract]    
Net loss $ (4,489) $ (4,724)
Other comprehensive gain (loss):    
Available for sale securities - net unrealized loss 0 (2)
Cumulative translation adjustment arising during the period 16 5
Total other comprehensive gain 16 3
Comprehensive loss attributable to Lisata Therapeutics, Inc. common stockholders $ (4,473) $ (4,721)